サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1526972

痛風性関節炎の世界市場レポート 2024年

Gouty Arthritis Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
痛風性関節炎の世界市場レポート 2024年
出版日: 2024年08月05日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

痛風性関節炎市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.3％で45億7,000万米ドルに成長します。この予測期間の成長は、医療インフラの強化、肥満率の上昇、痛風の罹患率の増加、国民の意識の高まりに起因しています。この期間に予想される主要動向には、効果的な代替治療に対する需要の急増、再生療法の進歩、技術革新、新製品の発売、規制当局の承認などが含まれます。

痛風性関節炎市場の成長は、肥満の有病率の増加によって牽引されると予測されます。肥満とは、過剰な体脂肪蓄積を特徴とする病状と定義され、多くの場合、体格指数（BMI）を用いて評価されます。肥満率の上昇は、高カロリー加工食品の消費量の増加と座りがちなライフスタイルに起因しています。この状態は、尿酸の産生を増加させる一方、尿酸の排泄を阻害し、関節に尿酸結晶を蓄積させることにより、痛風性関節炎の一因となります。さらに、過剰な体重は関節に負担をかけ、痛風に伴う炎症や痛みを悪化させる。例えば、スイスに本部を置く国連の専門機関である世界保健機関（WHO）が発表した2022年3月のデータでは、成人6億5,000万人、青少年3億4,000万人、幼児3,900万人を含む約10億人が肥満と分類され、この数は増加傾向にあります。また、2025年までに約1億6,700万人の成人と子どもが体重過多による健康問題を経験するとの予測もあります。その結果、肥満の蔓延が痛風性関節炎市場の拡大に拍車をかけています。

痛風性関節炎市場の主要企業は、コルトロフィンゲルのような革新的な製品を開発し、より効率的で的を絞った治療法を提供する努力を強めています。コルチコトロピン注射液とも呼ばれるコルチロフィンゲルは、副腎皮質刺激ホルモン（ACTH）を精製したもので、痛風性関節炎を含む様々な炎症性疾患や自己免疫疾患の治療に利用されています。例えば、2023年10月、米国の製薬会社ANI Pharmaceuticalsは、精製コルトロフィンゲルの新しい1mLバイアルサイズについて食品医薬品局から承認を得ました。本製品は、急性増悪期（痛風性関節炎）にある特定の患者に対する補助治療用に設計されています。現在、コルトロフィンゲルは、痛風性関節炎の急性症状を有する適切な患者の管理に適応される、FDA承認の唯一の副腎皮質刺激ホルモン（ACTH）療法です。

目次

第1章 エグゼクティブ概要

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の痛風性関節炎市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の痛風性関節炎市場の実績：規模と成長、2018～2023年
  • 世界の痛風性関節炎市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の痛風性関節炎市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 急性
  • 慢性
  • 世界の痛風性関節炎市場：治療別、実績と予測、2018～2023年、2023～2028年、2033年
  • 非ステロイド性抗炎症薬（NSAID）
  • 鎮痛剤
  • コルチコステロイド
  • キサンチンオキシダーゼ阻害剤
  • 尿酸排泄薬
  • その他
  • 世界の痛風性関節炎市場：診断別、実績と予測、2018～2023年、2023～2028年、2033年
  • 関節液試験
  • 血液試験
  • X線画像
  • 超音波
  • デュアルエネルギーCTスキャン
  • その他
  • 世界の痛風性関節炎市場：流通チャネル別、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院薬局
  • 小売薬局
  • その他流通チャネル
  • 世界の痛風性関節炎市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 専門クリニック
  • その他

第7章 地域別・国別分析

  • 世界の痛風性関節炎市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の痛風性関節炎市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 痛風性関節炎市場：競合情勢
  • 痛風性関節炎市場：企業プロファイル
    • Pfizer Inc.
    • Roche Holding AG
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Bayer AG

第31章 その他の大手企業と革新的企業

  • Bristol Myers Squibb
  • AstraZeneca plc
  • Novartis International AG
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Incorporated
  • UCB S.A.
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r18621

Gouty arthritis presents as an inflammatory joint condition marked by sudden, severe episodes of pain, swelling, and redness, commonly occurring in the big toe. This condition arises due to the buildup of uric acid crystals in the joints, triggering intense inflammation and discomfort. Management of gout involves a combination of medications and lifestyle adjustments aimed at reducing uric acid levels and preventing future flare-ups.

There are two primary types of gouty arthritis, acute and chronic. Acute gouty arthritis manifests abruptly, causing severe pain, swelling, and redness in the joints, often targeting the big toe. Treatment options encompass non-steroidal anti-inflammatory drugs (NSAIDs), pain relievers, corticosteroids, xanthine oxidase inhibitors, uricosurics, and diagnostic procedures such as joint fluid tests, blood tests, X-ray imaging, ultrasound, and dual-energy computed tomography (CT) scans. Distribution channels for these treatments include hospital and retail pharmacies, serving end-users such as hospitals, specialty clinics, and other healthcare facilities.

The gouty arthritis market research report is one of a series of new reports from The Business Research Company that provides gouty arthritis market statistics, including the gouty arthritis industry global market size, regional shares, competitors with the gouty arthritis market share, detailed gouty arthritis market segments, market trends, and opportunities, and any further data you may need to thrive in the gouty arthritis industry. These gouty arthritis market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gouty arthritis market size has grown strongly in recent years. It will grow from $3.21 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The historic period's growth can be attributed to several factors, including the widespread prevalence of chronic diseases, higher alcohol consumption rates, a growing elderly population, increased acceptance of advanced regenerative therapies, and escalating healthcare spending.

The gouty arthritis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The forecast period's growth can be credited to enhancements in healthcare infrastructure, rising obesity rates, a higher incidence of gout, and heightened awareness among the populace. Major trends expected in this period include a surge in demand for effective treatment alternatives, advancements in regenerative therapies, technological innovations, new product launches, and regulatory approvals.

The growth of the gouty arthritis market is anticipated to be driven by the increasing prevalence of obesity. Obesity is defined as a medical condition characterized by excessive body fat accumulation, often assessed using the body mass index (BMI). The rising obesity rates are attributed to elevated consumption of high-calorie processed foods and sedentary lifestyles. This condition contributes to gouty arthritis by elevating uric acid production while impairing its elimination, leading to uric acid crystal buildup in the joints. Moreover, excess body weight adds strain to joints, worsening the inflammation and pain associated with gout. For instance, data from March 2022 released by the World Health Organization, a specialized agency of the United Nations based in Switzerland focusing on global public health, revealed that around 1 billion people, including 650 million adults, 340 million adolescents, and 39 million children, were classified as obese, with this number on the rise. Projections also suggest that by 2025, approximately 167 million adults and children will experience health issues due to excess weight. Consequently, the growing prevalence of obesity is fueling the expansion of the gouty arthritis market.

Major players in the gouty arthritis market are intensifying their efforts to develop innovative products such as cortrophin gel to offer more efficient and targeted therapies for managing the condition. Cortrophin gel, also referred to as repository corticotropin injection, is a purified form of the adrenocorticotropic hormone (ACTH) utilized in treating various inflammatory and autoimmune disorders, including gouty arthritis. For instance, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical company, gained approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is designed for adjunctive treatment in specific patients experiencing acute gouty arthritis flares. Presently, Cortrophin Gel stands as the sole FDA-approved adrenocorticotropic hormone (ACTH) therapy indicated for managing appropriate patients with acute gouty arthritis flares.

In December 2022, Innovent Biologics Inc., a China-based biotechnology company, partnered with LG Chem Life Sciences to develop and market Tigulixostat, a novel non-purine xanthine oxidase inhibitor (XOI) for gout disease treatment. This collaboration aims to broaden treatment options for gout patients by introducing Tigulixostat into the Chinese market. LG Chem Life Sciences, a US-based pharmaceutical company, specializes in developing treatments for gouty arthritis.

Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.

North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gouty arthritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gouty arthritis market consists of revenues earned by entities by providing services such as diagnostic testing, physical therapy, pain management programs, and dietary counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The gouty arthritis market also includes sales of ibuprofen, naproxen, topical pain relievers, and ice packs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gouty Arthritis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gouty arthritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gouty arthritis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gouty arthritis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Acute Gouty Arthritis; Chronic Gouty Arthritis
  • 2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Pain Reliever; Corticosteroids; Xanthine Oxidase Inhibitors; Uricosurics; Others Treatments
  • 3) By Diagnosis: Joint Fluid Test; Blood Test; X-Ray Imaging; Ultrasound; Dual Energy Computed Tomography (CT) Scan; Other Diagnosis
  • 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Others Distribution Channels
  • 5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gouty Arthritis Market Characteristics

3. Gouty Arthritis Market Trends And Strategies

4. Gouty Arthritis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Gouty Arthritis Market Size and Growth

  • 5.1. Global Gouty Arthritis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gouty Arthritis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gouty Arthritis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gouty Arthritis Market Segmentation

  • 6.1. Global Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Acute Gouty Arthritis
  • Chronic Gouty Arthritis
  • 6.2. Global Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Pain Reliever
  • Corticosteroids
  • Xanthine Oxidase Inhibitors
  • Uricosurics
  • Others Treatments
  • 6.3. Global Gouty Arthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Joint Fluid Test
  • Blood Test
  • X-Ray Imaging
  • Ultrasound
  • Dual Energy Computed Tomography (CT) Scan
  • Other Diagnosis
  • 6.4. Global Gouty Arthritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others Distribution Channels
  • 6.5. Global Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-users

7. Gouty Arthritis Market Regional And Country Analysis

  • 7.1. Global Gouty Arthritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gouty Arthritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gouty Arthritis Market

  • 8.1. Asia-Pacific Gouty Arthritis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gouty Arthritis Market

  • 9.1. China Gouty Arthritis Market Overview
  • 9.2. China Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gouty Arthritis Market

  • 10.1. India Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gouty Arthritis Market

  • 11.1. Japan Gouty Arthritis Market Overview
  • 11.2. Japan Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gouty Arthritis Market

  • 12.1. Australia Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gouty Arthritis Market

  • 13.1. Indonesia Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gouty Arthritis Market

  • 14.1. South Korea Gouty Arthritis Market Overview
  • 14.2. South Korea Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gouty Arthritis Market

  • 15.1. Western Europe Gouty Arthritis Market Overview
  • 15.2. Western Europe Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gouty Arthritis Market

  • 16.1. UK Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gouty Arthritis Market

  • 17.1. Germany Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gouty Arthritis Market

  • 18.1. France Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gouty Arthritis Market

  • 19.1. Italy Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gouty Arthritis Market

  • 20.1. Spain Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gouty Arthritis Market

  • 21.1. Eastern Europe Gouty Arthritis Market Overview
  • 21.2. Eastern Europe Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gouty Arthritis Market

  • 22.1. Russia Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gouty Arthritis Market

  • 23.1. North America Gouty Arthritis Market Overview
  • 23.2. North America Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gouty Arthritis Market

  • 24.1. USA Gouty Arthritis Market Overview
  • 24.2. USA Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gouty Arthritis Market

  • 25.1. Canada Gouty Arthritis Market Overview
  • 25.2. Canada Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gouty Arthritis Market

  • 26.1. South America Gouty Arthritis Market Overview
  • 26.2. South America Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gouty Arthritis Market

  • 27.1. Brazil Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gouty Arthritis Market

  • 28.1. Middle East Gouty Arthritis Market Overview
  • 28.2. Middle East Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gouty Arthritis Market

  • 29.1. Africa Gouty Arthritis Market Overview
  • 29.2. Africa Gouty Arthritis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gouty Arthritis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gouty Arthritis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gouty Arthritis Market Competitive Landscape And Company Profiles

  • 30.1. Gouty Arthritis Market Competitive Landscape
  • 30.2. Gouty Arthritis Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Roche Holding AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Gouty Arthritis Market Other Major And Innovative Companies

  • 31.1. Bristol Myers Squibb
  • 31.2. AstraZeneca plc
  • 31.3. Novartis International AG
  • 31.4. Takeda Pharmaceutical Company Limited
  • 31.5. Eli Lilly and Company
  • 31.6. Amgen Inc.
  • 31.7. Gilead Sciences Inc.
  • 31.8. Viatris Inc.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. Regeneron Pharmaceuticals Inc.
  • 31.11. Biogen Inc.
  • 31.12. Vertex Pharmaceuticals Incorporated
  • 31.13. UCB S.A.
  • 31.14. Boehringer Ingelheim International GmbH
  • 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Gouty Arthritis Market Competitive Benchmarking

33. Global Gouty Arthritis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gouty Arthritis Market

35. Gouty Arthritis Market Future Outlook and Potential Analysis

  • 35.1 Gouty Arthritis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Gouty Arthritis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Gouty Arthritis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer